Research
Showing of 183 results
Oxford-Harrington Rare Disease Centre Announces David Cameron, Chair of its Advisory Council, as a Guest Speaker at Morgan Stanley Exchange 2025
In ‘A Conversation on Courage,’ Lord Cameron and Morgan Stanley’s Andy Saperstein discussed philanthropy as a catalyst for rare disease innovation.
University Hospitals Receives a $2.3 Million Grant from the John Templeton Foundation
The grant will support the project titled “Transforming Healthcare through the Power of Love: Expanding and Spreading the 'Living and Leading with Love' Framework”
Case Comprehensive Cancer Center receives $25.5M grant renewal to continue work in cancer treatment, prevention, and therapeutic innovation
The renewal marks 38 years of continuous NCI funding, dating back to the organization’s founding in 1987.
$5 million gift from Penni and Stephen Weinberg Will Support the Future Iris S. and Bert L. Wolstein Center at University Hospitals Cleveland Medical Center
Facility will be the epicenter of learning and connection at UH.
Team of Researchers, including University Hospitals Co–Senior Author, Finds not all Low-Grade Prostate Cancers are Low Risk
The study, published July 31 in the journal JAMA Oncology, found that one in six men with GG1 category cancer turns out to have intermediate- or high-risk cancer when other clinical features are considered in addition to biopsy results.
Researchers at University Hospitals and the Cleveland VA Say Long-Term Exercise Programs May Restore Neural Connections in Parkinson’s Patients
Investigators used deep brain stimulation devices to record brain signal changes after 12 dynamic cycling sessions.
University Hospitals, Case Western Reserve University and Siemens Healthineers Celebrate 40-plus Years in Radiology Innovation
Collaboration has driven more than $100 million in NIH funding, 217 invention disclosures, 136 U.S. patents, and 31 international patents.
David’s Warriors St. Baldrick’s Research Grant Awarded to UH Rainbow Physician Researcher for Pediatric Neuroblastoma Study
The grant will support Dr. John Letterio’s project titled, “Development of a Novel NF-κB Targeting Agent for Pediatric Neuroblastoma” focused on improving treatment outcomes for children with high-risk neuroblastoma.